New crowdfunding platform set to launch new biotechs

"You're not going to get a frog if you don't invest in the poliwogg." So says Gregory Simon, the CEO of Poliwogg, a new crowdfunding initiative for biotech, in an interview with Genetic Engineering & Biotechnology News. The idea here is to get crowdfunding to seed a company, which can get ramped up to the point that VCs can step in. "We fund these companies; they get across the 'valley of death' one way or another. They either fail, which is highly possible, or they succeed. They get a proof of concept." Story

 

Suggested Articles

Fifteen of the 22 patients in a gene therapy trial no longer needed transfusions, while the remainder needed fewer transfusions.

Argos Therapeutics is ending its kidney cancer trial and mulling options, including a merger or sale, to stay alive.

CNS Pharma says berubicin is the first anthracycline drug to cross the blood-brain barrier and could transform treatment of the highly invasive brain tumor.